Corcept Therapeutics reported $62.16M in Operating Expenses for its fourth fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Aurora Cannabis Inc ACB:CN 124.86M 23.96M
Canopy Growth Corp WEED:CN C$ 290.93M 55.8M
Corcept Therapeutics CORT:US $ 62.16M 2.26M
Depomed DEPO:US $ 19.54M 17.84M
Eleven Biotherapeutics EBIO:US 835K 10.21M
Lexicon Pharmaceuticals LXRX:US 23.42M 1.93M
Nektar Therapeutics NKTR:US $ 137.92M 598K
Novartis NOVN:VX 10.96B 826M
Tg Therapeutics TGTX:US $ 95.27M 8.11M
Ziopharm Oncology ZIOP:US $ 9.08M 1.97M